Cite
HARVARD Citation
Razvi, M. et al. (n.d.). Predictors of Vedolizumab Dose Escalation or Cessation in Inflammatory Bowel Disease Patients. American journal of gastroenterology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Razvi, M. et al. (n.d.). Predictors of Vedolizumab Dose Escalation or Cessation in Inflammatory Bowel Disease Patients. American journal of gastroenterology. p. . [Online].